Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

XGen
FDA Approves TRANEXAMIC ACID — XGen Pharmaceuticals DJB, Inc.

XGen Pharmaceuticals DJB, Inc. has received FDA approval for the intravenous formulation of tranexamic acid via ANDA 201580, enhancing the company’s p...

Ascend
FDA Approves MYCOPHENOLATE MOFETIL — Ascend Laboratories, LLC

Ascend Laboratories has received FDA approval for its generic version of CellCept (mycophenolate mofetil) to prevent organ transplant rejection. This ...

Upsher-Smith
FDA Approves MORPHINE SULFATE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC announced today the U.S. approval of its generic morphine sulfate, triggering a pivotal competition opportunity for man...

Novartis
FDA Approves TAFINLAR — Novartis Pharmaceuticals Corporation

# FDA Approves Novartis's TAFINLAR (Dabrafenib) for Melanoma Treatment Novartis Pharmaceuticals Corporation received FDA approval for TAFINLAR (dabra...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC

On May 28, 2013, SUN PHARM INDS INC secured regulatory approval for its abbreviated new drug application, a development likely to prompt significant m...

PAI
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — PAI Holdings, LLC dba PAI Pharma

PAI Holdings has secured FDA approval for its ANDA 040838, facilitating the market launch of hydrocodone bitartrate and acetaminophen, a widely utiliz...

Aurolife
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Aurolife Pharma, LLC

On April 15, 2013, Aurolife Pharma, LLC received FDA approval for the ANDA representing acetaminophen and codeine phosphate tablets. This authorizatio...

Janssen
FDA Approves INVOKANA — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals received FDA approval for INVOKANA, a novel SGLT2 inhibitor for the treatment of type 2 diabetes, which is poised to capture s...

Cranbury
FDA Approves TRAMADOL HYDROCHLORIDE — Cranbury Pharmaceuticals, LLC

Cranbury Pharmaceuticals, LLC received FDA approval for its ANDA covering Tramadol Hydrochloride tablets, granting the company authorization to market...

Teva
FDA Approves OLANZAPINE AND FLUOXETINE — Teva Pharmaceuticals USA, Inc.

# FDA Approves Generic Olanzapine and Fluoxetine Combination Teva Pharmaceuticals USA, Inc. received FDA approval for a generic version of the olanza...

BluePoint
FDA Approves ZENATANE — BluePoint Laboratories

# FDA Approves BluePoint Laboratories' Generic Isotretinoin (Zenatane) BluePoint Laboratories received FDA approval for Zenatane (isotretinoin) oral ...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS LTD

# FDA Approves Generic Drug Application for Sun Pharmaceutical Sun Pharmaceutical Industries Ltd. received FDA approval for ANDA091037 on February 22...

Genentech,
FDA Approves KADCYLA — Genentech, Inc.

Genentech announced today that the FDA has approved KADCYLA, an antibody-drug conjugate for HER2-positive breast cancer, signaling a strategic expansi...

Actavis
FDA Approves BUPRENORPHINE AND NALOXONE — Actavis Pharma, Inc.

Actavis Pharma, Inc. has secured FDA approval for its **buprenorphine and naloxone** (generic) tablets/sublingual film, expanding the availability of ...

Amneal
FDA Approves BUPRENORPHINE HCL AND NALOXONE HCL — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals has announced the FDA approval of its ANDA for buprenorphine and naloxone sublingual tablets, marking an entry into the competi...

Celgene
FDA Approves POMALYST — Celgene Corporation

# FDA Approves Celgene's POMALYST (pomalidomide) for Multiple Myeloma Treatment Celgene Corporation received FDA approval for POMALYST (pomalidomide)...

Chartwell
FDA Approves CALCIUM ACETATE — Chartwell RX LLC

Chartwell RX LLC announced FDA approval for its generic Calcium Acetate oral tablets, positioning the company to enter the competing marketplace for p...

BluePoint
FDA Approves DOXORUBICIN HYDROCHLORIDE — BluePoint Laboratories

BluePoint Laboratories announced U.S. approval of its revised intravenous formulation of doxorubicin hydrochloride, which aims to broaden patient acce...

Takeda
FDA Approves KAZANO — Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc.-sponsored KAZANO (alogliptin and metformin hydrochloride) tablets, an oral antidiabetic drug, received U.S. appro...

Actavis
FDA Approves MORPHINE SULFATE — Actavis Pharma, Inc.

Actavis Pharma, Inc. has received FDA approval for its Abbreviated New Drug Application (ANDA) for morphine sulfate oral solid dosage forms, potential...